During IPPE 2022 in Atlanta, Georgia, Sarah Muirhead from Feedstuffs 365 spoke with Amlan leadership about global poultry production trends and the background of Amlan’s natural mineral-based products. During the discussion, Dan Jaffee, President and CEO, Oil-Dri Corporation of America and President and General Manager of Amlan International, described the history of Amlan and the origin of the mineral that is the core of Amlan products.
Other discussion topics included global trends Fred Kao, VP of Global Sales, is observing in the poultry industry. Fred spoke about the increase in antibiotic-free poultry production in Brazil as producers adjust to new EU export requirements and the impact that African Swine Fever has had on poultry product demand in Asia.
Dr. Wade Robey, VP Global Marketing and Product Development, also detailed the benefits of two new Amlan products that were launched at IPPE (International products, not for sale in the US). One product is intended for application in antibiotic-free broiler production when pathogens are decreasing bird performance or when producers are trying to reduce pathogen levels entering the processing plant (NeutraPath®), and the other is a natural alternative to anticoccidial drugs and vaccines (Phylox®) for full time use or in a shuttle program when resistance to traditional coccidiostats is a concern. Both products also have excellent application potential in broiler breeders which are often challenged with coccidiosis and which can be very sensitive to mycotoxins and bacterial pathogens during grow-out and egg production.
Amlan International is excited to offer our North American customers an exclusive portfolio of mineral-based feed additives that support gut health and improve the sustainability of poultry and livestock production. The North American portfolio expands our efforts to support optimal intestinal health in protein-producing animals around the world.
Consumers in North America, like global consumers, demand high-quality animal protein raised without antibiotics. These consumer preferences, coupled with concerns about microbial resistance, have put producers under pressure to reduce the use of in-feed antibiotics. Consequently, North American producers and vertical integrators are seeking cost-effective, non-antibiotic, natural feed additives that support feed conversion and optimal intestinal health. Their search ends with our North American product range that can help with these challenges.
Our mineral-based feed additives offer multiple advantages for animal protein producers. The products support optimal gut health and meet the demands for cleaner food while reducing the inputs needed to raise production animals, helping to decrease the cost and environmental impact of poultry and livestock production.
Our North American sales and technical service team, led by Heath Wessels, Director of Sales and Technical Service for North America, is eager to partner with top-tier producers to help them achieve their production goals by integrating Amlan products into their operations. “Our natural feed additives are formulated to have strong synergy with each other for supporting optimal gut health,” said Heath. “We offer individual product solutions or can recommend product combinations for maximum results.”
The new product line will only be available for sale in North America but will be offered with the same excellence and reliability that global producers know and trust from our international product offerings. Amlan is vertically integrated as the animal health business of Oil-Dri® Corporation of America, allowing Amlan and Oil-Dri to control every step of the production process and reliably deliver safe, high-quality single-sourced products from company-owned mines.
The North American product portfolio strengthens our commitment to leading the industry in supplying natural feed additives that support animal intestinal health and add value for producers. Meet our products below, and if you have any questions about our North American product portfolio, please contact firstname.lastname@example.org.
A natural feed additive that yields performance results comparable to AGP use? It really does exist. Varium® supports a healthy intestinal tract AND can help provide production economics similar to antibiotic-fed birds.
As the animal health business of Oil-Dri® Corporation of America, Amlan International’s scientifically proven products are backed by Oil-Dri’s 80+ years of experience in mineral science. Amlan has access to the hundreds of millions of tons of mineral reserves that Oil-Dri, based and operating in the USA, selectively mines, processes and sells in a diverse range of industries throughout the world. Vertical integration allows Oil-Dri and Amlan to own every step of the production process and consistently deliver reliable non-medicated solutions to support animal protein producers around the world as they look to optimize animal health and production economics.
Safe Thermal Processing
The single-source raw material used in Amlan products is an all-natural mineral ingredient that contains high-capacity opal-CT lepispheres. This mineral is selected because its properties allow for thermal processing that is specifically talilored for each product. Thermal processing ensures the minerals’ structural integrity and optimizes the products’ broad utility, ultimately helping producers achieve normal animal health and meet their production goals.
Independent Assessments for Regulatory Requirements
Each quarter, all Amlan product lots are assessed by an independent laboratory to ensure they comply with regulatory requirements. These analyses ensure the mineral is below any established regulatory levels for dioxins (PCDD/F+PCB) and heavy metals (lead, cadmium, arsenic and mercury) in feed or food. This report is available upon request by contacting email@example.com. For both performance and safety, Amlan also performs extensive core drilling analyses of their raw material and selectively mines the highest quality raw materials for use in their products.
High-Quality Manufacturing Standards
All Amlan products are made to the highest industry standards for non-medicated feed additives to ensure their safety and consistent performance. Amlan’s quality systems are audited and certified annually by independent parties to demonstrate compliance.
Approved Feed Ingredients Only
Amlan’s feed additives only use ingredients that are approved for use in feed products by major regulatory bodies such as the U.S. FDA or the EU. This helps to secure the safety of the animal and, as Amlan’s products are developed for protein-producing animals, ensures end consumers are safe too. Amlan is proud to carry the Organic Materials Review Institute (OMRI) seal of approval on many of its products. OMRI Listed® products are approved for use in certified organic operations under the USDA National Organic Program.
High-Quality, Safe Products Are Paramount
Along with following ISO-9001 standards and a certified HACCP system, Amlan is also a certified International Safe Feed/Safe Food plant. This voluntary and independently certified program designed for the total feed industry establishes comprehensive standards of excellence that go beyond existing regulations to maximize food and feed safety. This certification assures customers that Amlan’s products are safe, healthy, trustworthy feed solutions. For all applicable products and production facilities, Amlan also meets the requirements set forth by FAMI/QS — a certification created exclusively for specialty feed ingredients and their mixtures. Many countries require the FAMI/QS certification to sell market specialty feed ingredients within their borders.
Mineral Technology Is the Amlan Difference
Amlan’s proprietary mineral technology is the foundation of their innovative products. In fact, multiple governments, including the United States, the European Union, China, Korea and Indonesia have recognized the unique mineral-based technology within Amlan’s products Varium® and NeoPrime® and have issued a patent for the products’ modes of action.
By leveraging their owned, unique mineral technology and committing to the highest quality standards, Amlan develops innovative and reliable natural, mineral-based feed additive solutions for poultry and livestock. To learn more about Amlan’s products, visit https://amlan.com/products/.
With cutting-edge equipment and state-of-the-art facilities, Amlan’s talented Life Sciences team creates value-adding mineral-based products for poultry and livestock producers. The Richard M. Jaffee Center for Applied Microbiology houses the specialized equipment used by the Life Sciences team who draw upon their extensive research experience and knowledge base to create novel, natural solutions that improve poultry and livestock health and production efficiency.
Life Science Experts
The Amlan research team is led by Life Sciences Director Hongyu Xue MD, PhD, an experienced scientist in clinical and animal nutrition, who brings a unique point of view to Amlan’s research by leveraging his expertise in human medicine. Dr. Xue has a background in academic medicine and research that cross-links gastroenterology, immunology, microbiology and nutrition. Working with Dr. Xue is a multi-disciplinary team of scientists with expertise across microbiology, animal nutrition, chemistry and material science areas. Several members of the Life Sciences team were recently featured on an episode of “Built in America: INNOVATION NATION” on the Fox Business Network, where they showcased some of their novel research.
The Life Sciences team enhances Amlan’s unique mineral to develop natural solutions that can control the microbial pathogens that negatively impact the health and productivity of poultry and livestock. To do this, the scientists study these pathogens and their toxins to understand their physiology and mode of action. Some pathogens require anerobic conditions to survive, so these pathogens are cultivated in Amlan’s anerobic chamber — a more efficient and robust method than alternative techniques such as anerobic jar or pouch systems.
Conditions within the chamber can perfectly mimic the anerobic environment of the distal gastrointestinal (GI) tract (e.g., ileum and cecum) which serves as the primary colonization site for a vast variety of common microbial pathogens for poultry and livestock. The anaerobic chamber is of tremendous value to help Amlan’s scientists cultivate and further characterize the target pathogens and select commensal microbial populations colonizing the distal GI tract. Further, the chamber also enables the scientists to screen novel products in development and evaluate their antimicrobial effects for certain anaerobic pathogens. Novel strains of beneficial bacteria (probiotics) can also be isolated, grown and tested in the anerobic chamber. The photo below shows an example of the zone of inhibition surrounding an Amlan-developed probiotic (right) versus a water control (left).
Further assessment of the new products can be conducted using equipment such as an ICP-OES (inductively coupled plasma-optical emission spectrometer) that allows the team to examine how different cations released by Amlan’s unique mineral affects bacterial virulence. Some metals (cations) are known to suppress the expression of virulence genes in bacterial pathogens.
The lab also includes a fluorescent microscope that enables microbes to be observed instantly to see a product’s effect on bacterial morphology and viability.
Using real-time polymerase chain reaction (PCR), the Life Sciences team have developed methods to detect toxin genes from microbial pathogens that can have negative effects on poultry and livestock production. Using this information, natural solutions can be developed that disarm these pathogens and help protect birds and animals from disease. For example, real-time PCR is used to investigate the effects of new products on pathogen virulence gene expression. Further, this technology can help determine the copy numbers of specific virulence genes and help make an early diagnosis of specific enteric diseases in poultry and livestock.
The Richard M. Jaffee Center for Applied Microbiology is named after the former chairman of Oil-Dri Corporation of America, doing business as Amlan International. Jaffee’s pioneering spirit and vision for Oil-Dri to conduct research in the life sciences is the influence behind Amlan’s focus on developing value-added next-generation animal health products.
The rise of multi-drug-resistant and mutant bacteria, which don’t respond to antibiotic treatment, is a concerning trend across the world. With the use of antibiotic growth promoters (AGPs) restricted in an increasing number of countries, livestock and poultry industries are looking for antibiotic-free alternatives that keep animals and birds healthy and productive. Amlan International’s Richard M. Jaffee Center for Applied Microbiology is developing industry-leading technology that helps livestock and poultry producers achieve peak antibiotic-free-performance.
Discovering new methods to combat the prevalence of resistant and mutant pathogens is just one of the topics scientists at the Richard M. Jaffee Center for Applied Microbiology are investigating. The research team at Amlan’s new state-of-the-art lab are using an antivirulence approach to control pathogens, which has also been a research focus for developing new antimicrobial drugs for humans.
Novel Alternative to Antibiotics
Unlike conventional antibiotics, antivirulence approach targets bacterial virulence factors and is aimed at disarming pathogens and modifying their behaviors by making them less harmful (less virulent) to the host. The likelihood for multi-drug-resistant and mutant bacteria is much less using this approach.
There are many options for controlling pathogens using an antivirulence approach. These antivirulence targets include:
Previous research at Amlan International showed exciting promise in the quorum sensing area. The Richard M. Jaffee Center for Applied Microbiology continues to conduct quorum sensing research as one component of the overall antivirulence approach to improving livestock and poultry health and production.
Bacteria Can Communicate
Quorum sensing is a communication system between bacterial cells that allows bacteria to regulate their activity in response to stimuli. This communication system involves bacteria releasing biochemicals into the environment which accumulate in the surrounding area until reaching a critical threshold concentration1. The biochemicals then bind to receptors on the bacteria, signaling gene expression.
Quorum sensing can control many functions in bacteria2 including:
Virulent gene expression
Quorum Quenching Silences Bacteria
Quorum quenching is an approach which can disrupt the quorum sensing system of pathogenic bacteria, preventing cell-to-cell communication and the expression of virulence genes that could lead to their infection in the host. Quorum quenching products should reduce the chance of antibiotic resistance, since they are modifying bacteria behavior rather than killing them.
Calibrin®-Z Disrupts Quorum Sensing
Evidence of quorum quenching by Amlan’s Calibrin®‑Z biotoxin control product was published in the Journal of Agricultural and Food Chemistry. The research team at the Richard M. Jaffee Center for Applied Microbiology are continuing to build on these positive results and further quorum sensing research.
The previous study illustrated that in vitro, quorum sensing molecules can be separated out by adsorption or catalytically broken down into small fragments by Calibrin-Z. By reducing the concentration of quorum sensing biochemicals, the products can potentially disrupt the ability of pathogenic bacteria to produce toxins or reduce their virulence, since these functions are controlled through quorum sensing.
Additionally, due to their stronger acidity, greater pore volume and greater surface area, in the same study Calibrin-Z performed better then silica, illite and kaolinite as catalysts/adsorbents in quorum sensing molecule removal.
When incubated with Vibrio harveyi, a bacterium that exhibits bioluminescence controlled via quorum signaling, Calibrin-Z reduced bacterial luminescence by 55% (from the area under the curve; Figure 1). While this demonstrated that interference in quorum sensing occurred, the bacterial numbers were not impacted, indicating the reduction in bioluminescence was achieved through quorum quenching and not by killing bacteria.
Figure 1: Bacterial luminescence from a Vibrio harveyi culture treated with different concentrations of Calibrin-Z. Vibrio parahaemolyticus (Vp) was used as a non-luminescent negative control. At 10 mg/mL, Calibrin-Z reduced bacterial luminescence by 55% (area under the curve).
Quorum sensing is just one of the virulence factors being investigated by the research team at the Richard M. Jaffee Center for Applied Microbiology. Similarly, the antivirulence approach is just one of the next-gen technologies that is being developed in the lab to maximize livestock and poultry producer’s profits by improving the health and productivity of their flock or herd.
Stay tuned for more information about the innovative research conducted inside the Richard M. Jaffee Center for Applied Microbiology.
Naik, S.P., Scholin, J., Ching, S., Chi, F. and Herpfer, M. (2018). Quorum Sensing Disruption in Vibrio harveyi Bacteria by Clay Materials. Journal of Agricultural and Food Chemistry, 66 (1), 40-44. DOI: 10.1021/acs.jafc.7b03918
Williams, P. (2007) Quorum Sensing, Communication and Cross Kingdom Signalling in the Bacterial World. Microbiology, 153 (12), 3923−3938. DOI: 10.1099/mic.0.2007/012856-0
Products that prevent pathogenic bacteria from communicating with each other? This is just one of the next‑generation technologies that scientists are developing at Amlan International’s innovative new and improved Richard M. Jaffee Center for Applied Microbiology.
Amlan’s commitment to microbiology research began when their original laboratory opened in 2017 and further strengthened with the expansion of the Richard M. Jaffee Center for Applied Microbiology in October 2019. The new center provides the company with a cutting‑edge facility to accelerate novel animal health and life sciences research. With state-of-the-art equipment, the R&D team can isolate and cultivate both beneficial and pathogenic bacteria and investigate the antimicrobial effects of Amlan’s next‑generation, natural products.
The new lab is a certified Biosafety Level 2 laboratory, equipped with the technical and diagnostic resources of a traditional microbiology lab, as well as molecular biology, immunology and cell biology capabilities. It’s located near the company’s original R&D center, the Nick Jaffee Center for Innovation in Vernon Hills, Illinois. The 6,000-square-foot facility houses the life sciences team and a high‑tech laboratory space.
Novel Approach to No-Antibiotics-Ever Production
By developing innovative animal health solutions for Amlan’s customers, the research team is simultaneously tackling the global issue of antibiotic resistance. The scientists are using an antivirulence approach to control enteric disease in livestock by developing products that can modify pathogen behavior, making them less virulent (friendlier). This antivirulence approach can improve the production and health of flocks or herds while reducing the tendency to select for resistant or mutant bacteria that is seen with the use of conventional antibiotics.
“The new lab allows our life science research team to access a wide variety of state-of-the-art equipment, such as real-time PCR, an anaerobic chamber and florescent microscopy,” says Dr. Hongyu Xue, Life Sciences Director at Amlan. “We are trying to disarm the microbial pathogens by targeting their virulence factors in this facility.”
The life sciences team can also analyze the synergistic capabilities of the company’s proprietary enterosorbent mineral formulated with other feed additives, leading to the development of new products that can provide even greater returns on investment for poultry and livestock producers.
By incorporating best production practices, natural feed additive programs and pioneering innovation that targets virulence factors, producers should be able to reduce inputs in animal diets, enhance intestinal health of food animals and improve production efficiency for the entire industry.
“This new lab enables us to bring new ideas and products to the marketplace like never before,” says Flemming Mahs, President, Amlan International. “Science and research are the foundation of our discovery process to improve animal performance by protecting their intestinal health.”
Stay tuned for more information about the innovative research conducted inside the Richard M. Jaffee Center for Applied Microbiology.
In educating consumers about the value and uses for natural mineral additives, Amlan is also focusing on ways to support integrators who are moving to antibiotic-free (ABF) production to meet consumer and regulatory demands.
In the August 30, 2020, episode of “Built in America: INNOVATION NATION” on the Fox Business Network, millions of viewers in the U.S. went behind the scenes at Amlan International to learn about the company’s extensive research into minerals and animal health. Through this research, Amlan’s patented products and mineral technologies aim to solve many problems in the livestock industry and more.
“We were incredibly honored to host the show and share how our products are part of the very diverse food supply chain to the public,” says Flemming L. Mahs, President of Amlan International. “We are proud of our extensive R&D team and are committed to creating a safe, nutritious food system.”
The show interviewed Amlan employees, industry leaders and walked through the many research laboratories at the Richard M. Jaffee Center for Applied Microbiology to understand what goes into their animal health product research.Watch the episode here.
In the episode, Dr. Glauber Sartori Maier, Animal Nutritionist for Coasul Cooperativa Agroindustrial, an agricultural cooperative with 9,000 associates in 28 cities in the southern part of Brazil, shared his company’s experiences incorporating Varium® as they moved to antibiotic-free poultry production.
Dr. Maier emphasizes the urgency of adopting innovative technology to produce enough quality food, at acceptable prices, for a growing world population. He says that Coasul exports nearly 30 million birds per year, which is about 60 percent of their total annual production. The company made adjustments to its production practices to accommodate global market demand for poultry raised without antibiotics.
“I have no doubt that antibiotic-free production will continue to grow in the world. It’s much easier to grow birds without the use of antibiotics to promote growth than producers realize,” Maier says.
When moving to ABF, Maier says it is important to make sure every other aspect of production is on point. Here are three areas that changed for Coasul:
Gut health is the key starting point. Improving feed conversion and production efficiency allowed birds to grow to the same weight with less feed.
Drier litter is also a result of improving gut health. Drier litter in chicken houses improves the health and quality of chicken feet, which is a very profitable, high-demand product in China.
Healthy birds are calmer. In general, healthier animals are less likely to peck or scratch other birds, which helps ensure the highest standards of meat quality and skin.
“Many producers are afraid to stop using antibiotics because they believe the performance of the animals will decline and it will result in spending more money to produce the same quantity of meat. In our case, the results are better using Varium, and our costs are lower,” Maier says.
For more information about transitioning to AFP in poultry, read these other blogs from Amlan International: